Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Steven Rachbach who wrote (267)	4/27/1999 5:58:00 PM
From: Elmer	Respond to of 1127

Hi Steven, I've owned the stock for years and have known about the clinical trials. But I always thought they had many years of cash to burn. It came home yesterday with the $12 million loss that the trials have to be successful or they will have cash problems in less than 4 years. That said, I own a lot of stock and believe it will work out. I just hope the phase II results (and phase III results) are successful. Regardless of the results, I think they have great science and think it would be a shame if a couple bad trials turned the street negative so that capital became a problem. But if the phase II and upcoming IIIs work out, the science will be validated and the stock will be up a ton. It will be HGSI.com.